MULTIFOCAL BREAST CARCINOMA
Clinical trials for MULTIFOCAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for MULTIFOCAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop aggressive breast Cancer's return
Disease control OngoingThis phase 3 trial tests whether adding tucatinib to the standard drug T-DM1 can better prevent HER2-positive breast cancer from returning in high-risk patients. About 1,056 participants who still have cancer after initial treatment will receive either T-DM1 alone or T-DM1 plus t…
Matched conditions: MULTIFOCAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
Landmark study refines chemo use for common breast cancer
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or aromatase inhibitors) either alone or with chemotherapy. The goal was to …
Matched conditions: MULTIFOCAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC